Should You Buy Leggett & Platt Inc (LEG) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
11.710
1 Day change
-1.60%
52 Week Range
12.770
Analysis Updated At
2026/01/26
Leggett & Platt (LEG) is not a strong buy at the moment for a long-term beginner investor. While the stock has potential catalysts like the acquisition proposal from Somnigroup and improved financial performance in Q3 2025, the technical indicators and current price trend suggest a lack of immediate upward momentum. Additionally, the absence of strong trading signals and the neutral sentiment from hedge funds and insiders make this stock more suitable for holding rather than buying now.
Technical Analysis
The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 46.894, showing no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 12.371, with key support at 12.058 and resistance at 12.685. Overall, the technical indicators suggest a mixed to slightly bearish trend.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
The high Put-Call Volume Ratio (1.36) indicates bearish sentiment in the options market, while the low Open Interest Put-Call Ratio (0.3) suggests limited downside protection demand.
Technical Summary
Sell
5
Buy
7
Positive Catalysts
Somnigroup's acquisition proposal at $12 per share, representing a 30% premium over the 30-day average price.
Improved financial performance in Q3 2025, with net income up 183.07% YoY and EPS up 175.76% YoY.
Bullish moving averages indicate some long-term support.
Neutral/Negative Catalysts
Regular market price dropped by -3.11%, indicating bearish sentiment.
MACD and RSI show no immediate bullish momentum.
Options data suggests bearish sentiment with a high Put-Call Volume Ratio of 1.36.
Financial Performance
In Q3 2025, revenue dropped by -5.93% YoY to $1.036 billion. However, net income increased significantly by 183.07% YoY to $127.1 million, and EPS rose by 175.76% YoY to 0.91. Gross margin also improved to 18.47%, up 4.82% YoY. The financials show strong profitability improvements despite declining revenue.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Analysts have mixed views. Piper Sandler raised the price target to $12 from $10 and views the Somnigroup acquisition as highly compelling. Truist and Goldman Sachs also raised price targets to $12 and $11, respectively, citing strategic initiatives and cost structure improvements. However, the ratings remain neutral, reflecting cautious optimism.
Wall Street analysts forecast LEG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LEG is 12 USD with a low forecast of 11 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast LEG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LEG is 12 USD with a low forecast of 11 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
3 Hold
0 Sell
Hold
Current: 11.900
Low
11
Averages
12
High
13
Current: 11.900
Low
11
Averages
12
High
13
Piper Sandler
Neutral
maintain
$10 -> $12
AI Analysis
2025-12-11
Reason
Piper Sandler
Price Target
$10 -> $12
AI Analysis
2025-12-11
maintain
Neutral
Reason
Piper Sandler raised the firm's price target on Leggett & Platt (LEG) to $12 from $10 and keeps a Neutral rating on the shares. The firm notes that early last week, Somnigroup (SGI) proposed acquiring Leggett in an all-stock transaction. After having numerous industry discussions over the last week, and doing high level merger math, Piper now views the deal as highly compelling with potential to be highly accretive both immediately and over several years.
BNP Paribas Exane
Samuel King
Underperform -> Outperform
upgrade
€84
2025-12-05
Reason
BNP Paribas Exane
Samuel King
Price Target
€84
2025-12-05
upgrade
Underperform -> Outperform
Reason
BNP Paribas Exane analyst Samuel King upgraded LEG Immobilien to Outperform from Underperform with an EUR 84 price target. The firm sees an attractive valuation at current share levels.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LEG
